Novo Nordisk's pricing procedures from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of rate gouging, mentioning the stark contrast involving U.S. costs and people in Europe and copyright. But Rybelsus and copyright do have some